Monday, 10 August 2020


Ajinomoto Bio completes acquisition of Granules JV in India

03 June 2020 | News

Purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited

Image credit- shutterstock.com

Image credit- shutterstock.com

Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that it has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.

The transaction, announced in August 2019, strengthens Aji Bio-Pharma's commitment to providing its clients accessibility to a reliable and simplified CDMO supply chain across all sites globally.

Now doing business as Ajinomoto Bio-Pharma Services India (Aji Bio-Pharma India), the organization is fully integrated into Aji Bio-Pharma's global operations.

The Visakhapatnam, India site, which was designed, constructed and is managed based on the Aji Bio-Pharma Belgian sites' GMP operating standards and quality systems, has successfully supported a number of the world's leading biopharmaceutical companies since its formation in 2011.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls